Page 10 - Functional Genomics News Today

Share this article Share this article DANVILLE, Pa., April 29, 2021 /PRNewswire/ -- The National Cancer Institute (NCI), part of the National Institutes of Health, has awarded a 5-year, $3.6 million contract to Geisinger to study the role of genetic variation in cancer. Researchers from Geisinger and the NCIs Division of Cancer Epidemiology and Genetics (DCEG) will analyze genetic data from Geisingers MyCode Community Health Initiative, a precision medicine project with more than 276,000 conse...

Geisinger wins $3.6 million contract to study the role of genetic variation in cancer The National Cancer Institute (NCI), part of the National Institutes of Health, has awarded a 5-year, $3.6 million contract to Geisinger to study the role of genetic variation in cancer. Researchers from Geisinger and the NCIs Division of Cancer Epidemiology and Genetics (DCEG) will analyze genetic data from Geisingers MyCode Community Health Initiative, a precision medicine project with more than 276,000 cons...

Metabolomics Global Market Report 2021: COVID-19 Growth And Change To 2030 The Business Research Company’s Metabolomics Global Market Report 2021: COVID-19 Growth And Change To 2030 LONDON, GREATER LONDON , UK, April 14, 2021 /EINPresswire.com/ -- According to the new market research report ‘Metabolomics Global Market Report 2021: COVID-19 Growth And Change To 2030’ published by The Business Research Company, the metabolomics market is expected to reach $3.6 billion in 2025 at a CAGR of 1...

Researchers at Beaumont Health have discovered a blood test that may provide an early prediction of Alzheimer’s disease in patients.

Dr. Penny Riggs is an Associate Professor of Functional Genomics in the Department of Animal Science and serves as Associate Vice President for Research at Texas A&M University. She is an adjunct member of the Department of Veterinary Integrative Biosciences. Her current research focuses on analysis of gene, RNA and protein expression, function and signaling relevant to the inheritance of production traits and disease susceptibility in beef cattle and other food animals, particularly in skelet...

Author of the article: Nugget Staff Publishing date: Mar 16, 2021  •  March 16, 2021  •  2 minute read  •  Tara McGoey, left, outlines some of the results of a DNA sequencing operation to Kashif Khan, CEO of The DNA Company, Nipissing-Timiskaming MP Anthony Rota and Canadore College president George Burton, in September, 2019, at the official opening of the Functional Genomics Lab at Canadore. The lab will be part of a provincewide effort to sequence and characterize coronavirus...

Scientists to extract ancient bacteria from Batagai depression in bid to create new antibiotic range 04 March 2021 Expedition to the world’s biggest permafrost ‘crater’ in Yakutia seeks secret of taming antimicrobial resistance. We see that the situation with antibiotic resistance is very difficult indeed, and it is in the interests of both us (as scientists) and society to obtain prototypes of drugs for the treatment of hospital-obtained infections, and then bring them to produc...

A little more than two centuries ago, an English novelist named Frances Burney endured a “terrible operation” to remove a tumour after having breast cancer diagnosed. Burney spent more than 17 agonising minutes under the scalpel as her surgeon in Paris cut away at her breast – all without anaesthetic. She was 58 when the mastectomy was performed and lived another three decades, a happy outcome that went against the terrible odds faced by cancer patients at the time. Fast forward to to...

Press release content from Business Wire. The AP news staff was not involved in its creation. Athersys Announces CEO Transition CLEVELAND, Ohio--(BUSINESS WIRE)--Feb 16, 2021-- Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem ® cell therapy, today announced that Dr. Gil Van Bokkelen has stepped down as Chairman and Chief Executive Officer, effective immediately. The Athersys Board has appointed William (B.J.) Lehmann, the Company’s President and Chief Opera...

Homegrown coronavirus variants are on the rise in the U.S. How worried should Americans be? Andrew Romano © Provided by Yahoo! Lifestyle In recent weeks, Americans have been waiting with bated breath for the arrival of worrisome overseas variants of SARS-CoV-2 — the coronavirus that causes COVID-19. We’ve all heard of B.1.1.7 (the so-called U.K. variant), B.1.351 (the so-called South Africa variant) and P.1 (the so-called Brazil variant). We’re dimly aware of how they wo...